BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17431579)

  • 1. Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
    Grarup N; Albrechtsen A; Ek J; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
    Diabetologia; 2007 Jun; 50(6):1201-8. PubMed ID: 17431579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
    Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
    Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.
    Villegas R; Williams S; Gao Y; Cai Q; Li H; Elasy T; Cai H; Edwards T; Xiang YB; Zheng W; Long J; Ou Shu X
    Ann Hum Genet; 2011 Sep; 75(5):621-9. PubMed ID: 21834910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese.
    Lu L; Wu Y; Qi Q; Liu C; Gan W; Zhu J; Li H; Lin X
    PLoS One; 2012; 7(4):e34895. PubMed ID: 22509365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
    Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
    Tang L; Lü Q; Cao H; Yang Q; Tong N
    Gene; 2016 Jul; 585(2):191-5. PubMed ID: 26915488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of
    Song J; Li N; Hu R; Yu Y; Xu K; Ling H; Lu Q; Yang T; Wang T; Yin X
    Front Endocrinol (Lausanne); 2022; 13():949990. PubMed ID: 36051387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of peroxisome proliferator-activated receptor-delta polymorphisms with sugar metabolism indices and tumor necrosis factor alpha level.
    Yu XJ; Su BL; Wang XM; Feng HJ; Jin CJ
    Genet Mol Res; 2014 Jul; 13(3):5088-93. PubMed ID: 25061733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARD rs7770619 polymorphism in a Korean population: Association with plasma malondialdehyde and impaired fasting glucose or newly diagnosed type 2 diabetes.
    Kim M; Kim M; Yoo HJ; Sun Y; Lee SH; Lee JH
    Diab Vasc Dis Res; 2018 Jul; 15(4):360-363. PubMed ID: 29776318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C161-->T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptor gamma.
    Moffett SP; Feingold E; Barmada MM; Damcott CM; Marshall JA; Hamman RF; Ferrell RE
    Metabolism; 2005 Nov; 54(11):1552-6. PubMed ID: 16253648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects.
    Andersen G; Burgdorf KS; Sparsø T; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabetes; 2008 May; 57(5):1427-32. PubMed ID: 18316360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-delta genotype influences metabolic phenotype and may influence lipid response to statin therapy in humans: a genetics of diabetes audit and research Tayside study.
    Burch LR; Donnelly LA; Doney AS; Brady J; Tommasi AM; Whitley AL; Goddard C; Morris AD; Hansen MK; Palmer CN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1830-7. PubMed ID: 20200337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.
    Vänttinen M; Nuutila P; Kuulasmaa T; Pihlajamäki J; Hällsten K; Virtanen KA; Lautamäki R; Peltoniemi P; Takala T; Viljanen AP; Knuuti J; Laakso M
    Diabetes; 2005 Dec; 54(12):3587-91. PubMed ID: 16306381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children.
    Burch LR; Zhou K; Donnelly LA; Doney AS; Brady J; Goddard C; Morris AD; Hansen MK; Palmer CN
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2587-93. PubMed ID: 19383774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population.
    Kim M; Kim M; Yoo HJ; Shon J; Lee JH
    Hum Genomics; 2018 Jun; 12(1):28. PubMed ID: 29914579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
    Wang T; Song JF; Zhou XY; Li CL; Yin XX; Lu Q
    BMC Med Genomics; 2021 Nov; 14(1):267. PubMed ID: 34772419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor delta +294T > C polymorphism and alcohol consumption on serum lipid levels.
    Wei XL; Yin RX; Miao L; Wu DF
    Lipids Health Dis; 2011 Dec; 10():242. PubMed ID: 22192471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects.
    Grarup N; Urhammer SA; Ek J; Albrechtsen A; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabetologia; 2006 Sep; 49(9):2097-104. PubMed ID: 16865358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population.
    Robiou-du-Pont S; Bonnefond A; Yengo L; Vaillant E; Lobbens S; Durand E; Weill J; Lantieri O; Balkau B; Charpentier G; Marre M; Froguel P; Meyre D
    Int J Obes (Lond); 2013 Jul; 37(7):980-5. PubMed ID: 23090577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.